Medical Care Expenditures for Individuals with Prediabetes: The Potential Cost Savings in Reducing the Risk of Developing Diabetes

Overview

Journal Popul Health Manag

Publisher Mary Ann Liebert

Specialties Health Services
Public Health

Date 2017 Feb 14

PMID 28192030

Citations 19

Authors

Tamkeen Khan

Stavros Tsipas

Gregory Wozniak

Affiliations

Soon will be listed here.

Abstract

The United States has 86 million adults with prediabetes. Individuals with prediabetes can prevent or delay the development of type 2 diabetes through lifestyle modifications such as participation in the National Diabetes Prevention Program (DPP), thereby mitigating the medical and economic burdens associated with diabetes. A cohort analysis of a commercially insured population was conducted using individual-level claims data from Truven Health MarketScan Lab Database to identify adults with prediabetes, track whether they develop diabetes, and compare medical expenditures for those who are newly diagnosed with diabetes to those who are not. This study then illustrates how reducing the risk of developing diabetes by participation in an evidence-based lifestyle change program could yield both positive net savings on medical care expenditures and return on investment (ROI). Annual expenditures are found to be nearly one third higher for those who develop diabetes in subsequent years relative to those who do not transition from prediabetes to diabetes, with an average difference of $2671 per year. At that cost differential, the 3-year ROI for a National DPP is estimated to be as high as 42%. The results show the importance and economic benefits of participation in lifestyle intervention programs to prevent or delay the onset of type 2 diabetes.

Citing Articles

From diabetes care to prevention: review of prediabetes apps in the DACH region.

Lim D, Meier L, Cadwell K, Jacob C Mhealth. 2025; 11:8.

PMID: 39944857 PMC: 11811653. DOI: 10.21037/mhealth-24-57.

Primary care providers' perspectives on referrals to the Diabetes Prevention Programme: a qualitative comparative study across varied referral patterns.

Stephenson-Hunter C, Gonzalez C, Franco S, Hashmi M, Tisor O, Gonzalez C BMJ Nutr Prev Health. 2025; 7(2):e000932.

PMID: 39882293 PMC: 11773654. DOI: 10.1136/bmjnph-2024-000932.

Prevalence of Testing for Diabetes Among US Adults With Overweight or Obesity, 2016-2019.

Chen Y, Lundeen E, Koyama A, Kompaniyets L, Andes L, Benoit S Prev Chronic Dis. 2023; 20:E116.

PMID: 38154119 PMC: 10756652. DOI: 10.5888/pcd20.230173.

Telehealth Diabetes Prevention Program for Adults With Prediabetes in an Academic Medical Center Setting: Protocol for a Hybrid Type III Trial.

Gamble A, Khan T, Hughes A, Guo Y, Vasaitis S, Bidwell J JMIR Res Protoc. 2023; 12:e50183.

PMID: 37955955 PMC: 10682930. DOI: 10.2196/50183.

Medical expenditure trajectory and HbA1c progression prior to and after clinical diagnosis of type 2 diabetes in a commercially insured population in the USA.

Pagan L, Yang W, Shao H, Wang Y, Zhang P BMJ Open Diabetes Res Care. 2023; 11(6).

PMID: 37914345 PMC: 10626875. DOI: 10.1136/bmjdrc-2023-003397.

References

Nichols G, Brown J . Higher medical care costs accompany impaired fasting glucose. Diabetes Care. 2005; 28(9):2223-9. PMC: 1383774. DOI: 10.2337/diacare.28.9.2223. View

. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

Vojta D, De Sa J, Prospect T, Stevens S . Effective interventions for stemming the growing crisis of diabetes and prediabetes: a national payer's perspective. Health Aff (Millwood). 2012; 31(1):20-6. DOI: 10.1377/hlthaff.2011.0327. View

Huang E, Basu A, OGrady M, Capretta J . Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009; 32(12):2225-9. PMC: 2782981. DOI: 10.2337/dc09-0459. View

Chatterjee R, Narayan K, Lipscomb J, Phillips L . Screening adults for pre-diabetes and diabetes may be cost-saving. Diabetes Care. 2010; 33(7):1484-90. PMC: 2890345. DOI: 10.2337/dc10-0054. View

. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002; 25(12):2165-71. PMC: 1282458. DOI: 10.2337/diacare.25.12.2165. View

Volpp K, Asch D, Galvin R, Loewenstein G . Redesigning employee health incentives--lessons from behavioral economics. N Engl J Med. 2011; 365(5):388-90. PMC: 3696722. DOI: 10.1056/NEJMp1105966. View

Zhang Y, Dall T, Chen Y, Baldwin A, Yang W, Mann S . Medical cost associated with prediabetes. Popul Health Manag. 2009; 12(3):157-63. DOI: 10.1089/pop.2009.12302. View

. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013; 36(4):1033-46. PMC: 3609540. DOI: 10.2337/dc12-2625. View

10.

Ramsey S, Summers K, Leong S, Birnbaum H, Kemner J, Greenberg P . Productivity and medical costs of diabetes in a large employer population. Diabetes Care. 2002; 25(1):23-9. DOI: 10.2337/diacare.25.1.23. View

11.

Li R, Qu S, Zhang P, Chattopadhyay S, Gregg E, Albright A . Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015; 163(6):452-60. PMC: 4913890. DOI: 10.7326/M15-0469. View

12.

Sepah S, Jiang L, Peters A . Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards. Diabetes Educ. 2014; 40(4):435-443. DOI: 10.1177/0145721714531339. View

13.

Herman W, Hoerger T, Brandle M, Hicks K, Sorensen S, Zhang P . The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005; 142(5):323-32. PMC: 2701392. DOI: 10.7326/0003-4819-142-5-200503010-00007. View

14.

James C, Bullard K, Rolka D, Geiss L, Williams D, Cowie C . Implications of alternative definitions of prediabetes for prevalence in U.S. adults. Diabetes Care. 2011; 34(2):387-91. PMC: 3024354. DOI: 10.2337/dc10-1314. View

15.

Goetzel R, Long S, Ozminkowski R, Hawkins K, Wang S, Lynch W . Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med. 2004; 46(4):398-412. DOI: 10.1097/01.jom.0000121151.40413.bd. View

16.

Dall T, Zhang Y, Chen Y, Quick W, Yang W, Fogli J . The economic burden of diabetes. Health Aff (Millwood). 2010; 29(2):297-303. DOI: 10.1377/hlthaff.2009.0155. View

17.

Su W, Chen F, Dall T, Iacobucci W, Perreault L . Return on Investment for Digital Behavioral Counseling in Patients With Prediabetes and Cardiovascular Disease. Prev Chronic Dis. 2016; 13:E13. PMC: 4747438. DOI: 10.5888/pcd13.150357. View

18.

. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012; 35(4):723-30. PMC: 3308273. DOI: 10.2337/dc11-1468. View

19.

Ackermann R, Holmes A, Saha C . Designing a natural experiment to evaluate a national health care-community partnership to prevent type 2 diabetes. Prev Chronic Dis. 2013; 10:E12. PMC: 3562224. DOI: 10.5888/pcd10.120149. View

20.

Ali M, Echouffo-Tcheugui J, Williamson D . How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program?. Health Aff (Millwood). 2012; 31(1):67-75. DOI: 10.1377/hlthaff.2011.1009. View